{"disease":{"id":"neurological-autoimmune-diseases","name":"neurological autoimmune diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06235580","title":"Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT03490539","title":"Disease-Modifying Treatments for Myasthenia Gravis","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04104620","title":"Autoimmunity in Patients With GAD-Ab and Their Relatives","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07197099","title":"Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT04687332","title":"IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University Medical Center Mainz","has_results":false},{"nct_id":"NCT07021209","title":"GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT07275736","title":"A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Juventas Cell Therapy Ltd.","has_results":false},{"nct_id":"NCT07265206","title":"A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Juventas Cell Therapy Ltd.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}